CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Clinical trials for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS trials appear
Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Year-long study probes safety of nasal polyp drug for chronic sinus sufferers
Disease control ENROLLING_BY_INVITATIONThis study aims to check the long-term safety of a drug called itepekimab for adults with chronic sinusitis and nasal polyps. It is for people who have already finished a previous 52-week study with this drug. The main goal is to see if the treatment remains safe and tolerable ov…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New shot tested to shrink stubborn nasal polyps
Disease control OngoingThis study is testing whether a new injectable drug called lunsekimig can safely reduce nasal polyps and improve symptoms in adults with chronic sinusitis. Participants will receive either the drug or a placebo for 24 weeks to see which is more effective. The goal is to find a be…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 17, 2026 13:07 UTC
-
New drug aims to shrink nasal polyps and ease breathing
Disease control OngoingThis study is testing whether a new injectable drug called GR1802 can help adults with severe chronic sinusitis and nasal polyps. Researchers want to see if the drug can shrink polyps, improve breathing and smell, and reduce the need for surgery or steroid pills. Over 200 partici…
Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Phase: PHASE3 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC